Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Butts

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
The American Surgeon|April 10, 2024
A Single Hospital-Wide Antibiogram is Insufficient to Account for Differences in Antibiotic Resistance Patterns Across Multiple ICUsShem K Blackley, Jay Lawrence, Addison Blevins, et al.
Current Oncology (Toronto, Ont.)|June 23, 2016
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancerB Melosky, J Agulnik, R Albadine, et al.
Current Oncology (Toronto, Ont.)|November 23, 2018
Canadian perspectives: update on inhibition of <i>ALK</i>-positive tumours in advanced non-small-cell lung cancerB Melosky, P Cheema, J Agulnik, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
The Mount Sinai Journal of Medicine, New York|November 21, 2008
Diversity in academic medicine no. 6 successful programs in minority faculty development: ingredients of successSandra P Daley, Ann-Gel Palermo, Marc Nivet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastasesE E Vokes, N Ready, E Felip, et al.
Cell Reports|March 8, 2025
Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson's diseaseThomas P Spargo, Chloe F Sands, Isabella R Juan, et al.
Nature|February 25, 2026
Functional dissection of complex trait variants at single-nucleotide resolutionLayla Siraj, Rodrigo I Castro, Hannah B Dewey, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
The American Surgeon|April 10, 2024
A Single Hospital-Wide Antibiogram is Insufficient to Account for Differences in Antibiotic Resistance Patterns Across Multiple ICUsShem K Blackley, Jay Lawrence, Addison Blevins, et al.
Current Oncology (Toronto, Ont.)|June 23, 2016
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancerB Melosky, J Agulnik, R Albadine, et al.
Current Oncology (Toronto, Ont.)|November 23, 2018
Canadian perspectives: update on inhibition of <i>ALK</i>-positive tumours in advanced non-small-cell lung cancerB Melosky, P Cheema, J Agulnik, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
The Mount Sinai Journal of Medicine, New York|November 21, 2008
Diversity in academic medicine no. 6 successful programs in minority faculty development: ingredients of successSandra P Daley, Ann-Gel Palermo, Marc Nivet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastasesE E Vokes, N Ready, E Felip, et al.
Cell Reports|March 8, 2025
Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson's diseaseThomas P Spargo, Chloe F Sands, Isabella R Juan, et al.
Nature|February 25, 2026
Functional dissection of complex trait variants at single-nucleotide resolutionLayla Siraj, Rodrigo I Castro, Hannah B Dewey, et al.
Pageof 10